Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | ||||
---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |||
Abdominal pain | x | ||||||
Anxiety | x | ||||||
Arrhythmia | x | ||||||
Asthenia | x | ||||||
Cellulitis | x | x | |||||
Confusional state | x | ||||||
Dyspnoea | x | ||||||
Rash | x | ||||||
Extravasation | x | x | |||||
Fatigue | x | ||||||
Flatulence | x | ||||||
Hyperkalaemia | x | x | x | ||||
Hypernatraemia | x | ||||||
Irritability | x | ||||||
Nausea | x | x | x | ||||
Necrosis | x | x | |||||
Numbness | x | ||||||
Tetany | x | ||||||
Ulcer | x | x | |||||
Vomiting | x | x | x | ||||
Abdominal discomfort | x | x | |||||
Warmth | x | x | |||||
Tingling sensation | x | ||||||
Gastrointestinal tract irritation | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |